ChemicalBook > Product Catalog >Biochemical Engineering >Inhibitors >PI3K / Akt / mTOR >PI3K inhibitor >BAY 80-6946 (Copanlisib)

BAY 80-6946 (Copanlisib)

BAY 80-6946 (Copanlisib) Structure
CAS No.
1032568-63-0
Chemical Name:
BAY 80-6946 (Copanlisib)
Synonyms
Copanlisib;BAY80-6946;CS-2321;Aliqopa);Copanlisib base;Copanlisib free base;Copanlisib(BAY80-6946);BAY 80-6946 (BAY80-6946;BAY 80-6946 (Copanlisib);BAY 80-6946 (Copanlisib) USP/EP/BP
CBNumber:
CB52616024
Molecular Formula:
C23H28N8O4
Molecular Weight:
480.52
MOL File:
1032568-63-0.mol
MSDS File:
SDS
Modify Date:
2024/7/2 8:55:11

BAY 80-6946 (Copanlisib) Properties

Density 1.51
storage temp. Store at -20°C
solubility insoluble in DMSO; insoluble in H2O; insoluble in EtOH
form solid
pka 8.42±0.20(Predicted)
color Off-white to light brown

SAFETY

Risk and Safety Statements

Symbol(GHS) 
GHS07
Signal word  Warning
Hazard statements  H302-H315-H319-H335
Precautionary statements  P261-P305+P351+P338
NFPA 704
0
2 0

BAY 80-6946 (Copanlisib) Chemical Properties,Uses,Production

brand name

Aliqopa

General Description

Class: lipid kinase; Treatment: FL (IV infusion); Other name: BAY 80-6946; Elimination half-life = 52 h (IV); Protein binding = 84.2%

Pharmacokinetics

Copanlisib has poor oral bioavailability due to low permeability and poor solubility, and therefore, it is not suitable for an oral medication. Consequently, it was developed as an IV drug. IV infusion of copanlisib resulted in rapid distribution throughout the body and a prolonged elimination half-life (52 h).

target

pan-PI3K

Metabolism

Copanlisib was the predominant component in human plasma, accounting for 84% of total radioactivity AUC, and the morpholinone metabolite 6 was the only circulating metabolite (about 5%).
Metabolic pathway of copanlisib in humans.

BAY 80-6946 (Copanlisib) Preparation Products And Raw materials

Raw materials

Preparation Products

Global( 148)Suppliers
Supplier Tel Country ProdList Advantage Inquiry
CLEARSYNTH LABS LTD. +91-22-45045900 Hyderabad, India 6351 58 Inquiry
A.J Chemicals 91-9810153283 New Delhi, India 6124 58 Inquiry
Pharma Affiliates 172-5066494 Haryana, India 6761 58 Inquiry
SynZeal Research Pvt Ltd +1 226-802-2078 Gujarat, India 6522 58 Inquiry
Pharmaffiliates Analytics and Synthetics P. Ltd +91-172-5066494 Haryana, India 6773 58 Inquiry
Henan Tianfu Chemical Co.,Ltd. +86-0371-55170693 +86-19937530512 China 21676 55 Inquiry
ATK CHEMICAL COMPANY LIMITED +undefined-21-51877795 China 32760 60 Inquiry
career henan chemical co +86-0371-86658258 +8613203830695 China 29901 58 Inquiry
BOC Sciences +1-631-485-4226 United States 19553 58 Inquiry
Chongqing Chemdad Co., Ltd +86-023-6139-8061 +86-86-13650506873 China 39916 58 Inquiry

BAY 80-6946 (Copanlisib) Spectrum

1032568-63-0(BAY 80-6946 (Copanlisib))Related Search:

2-Amino-N-[2,3-dihydro-7-methoxy-8-[3-(4-morpholinyl)propoxy]imidazo[1,2-c]quinazolin-5-yl]-5-pyrimidinecarboxamide 5-Pyrimidinecarboxamide, 2-amino-N-[2,3-dihydro-7-methoxy-8-[3-(4-morpholinyl)propoxy]imidazo[1,2-c]quinazolin-5-yl]- Copanlisib(BAY80-6946) BAY 80-6946 (Copanlisib) 7-methoxy-8-(3-morpholinopropoxy)-2,3-dihydroimidazo[1,2-c]quinazolin-5-amine Aliqopa) BAY 80-6946 (Copanlisib) USP/EP/BP Copanlisib free base BAY 80-6946; BAY80-6946; BAY-80-6946; BAY806946; BAY-806946; BAY 806946; COPANLISIB FREE BASE CS-2321 BAY 80-6946 (BAY80-6946 Copanlisib base Copanlisib, 98%, an ATP-competitive selective class-I PI3 kinases inhibitor BAY80-6946 Copanlisib 2-Amino-N-(7-methoxy-8-(3-morpholinopropoxy)-2,3-dihydroimidazo[1,2-c]quinazolin-5-yl)pyrimidine-5-carboxamide 1032568-63-0 C23H28N8O4 Inhibitors Akt mTOR PI3K PI3K/Akt/mTOR